DE69911557D1 - Imidazoline Derivate,ihre Herstellung und pharmazeutische Zusammensetzungen die sie enthalten - Google Patents
Imidazoline Derivate,ihre Herstellung und pharmazeutische Zusammensetzungen die sie enthaltenInfo
- Publication number
- DE69911557D1 DE69911557D1 DE69911557T DE69911557T DE69911557D1 DE 69911557 D1 DE69911557 D1 DE 69911557D1 DE 69911557 T DE69911557 T DE 69911557T DE 69911557 T DE69911557 T DE 69911557T DE 69911557 D1 DE69911557 D1 DE 69911557D1
- Authority
- DE
- Germany
- Prior art keywords
- alkyl
- imidazoline derivatives
- preparation
- pharmaceutical compositions
- compositions containing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/06—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms
- C07D233/08—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms with alkyl radicals, containing more than four carbon atoms, directly attached to ring carbon atoms
- C07D233/10—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms with alkyl radicals, containing more than four carbon atoms, directly attached to ring carbon atoms with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D233/22—Radicals substituted by oxygen atoms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9815999 | 1998-12-18 | ||
| FR9815999A FR2787451B1 (fr) | 1998-12-18 | 1998-12-18 | Nouveaux composes imidazoliniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE69911557D1 true DE69911557D1 (de) | 2003-10-30 |
| DE69911557T2 DE69911557T2 (de) | 2004-06-17 |
Family
ID=9534132
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69911557T Expired - Lifetime DE69911557T2 (de) | 1998-12-18 | 1999-12-17 | Imidazoline Derivate,ihre Herstellung und pharmazeutische Zusammensetzungen die sie enthalten |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US6127396A (de) |
| EP (1) | EP1010693B1 (de) |
| JP (1) | JP3526800B2 (de) |
| KR (1) | KR100492160B1 (de) |
| CN (1) | CN1183907C (de) |
| AT (1) | ATE250586T1 (de) |
| AU (1) | AU767856B2 (de) |
| BR (1) | BR9907497A (de) |
| CA (1) | CA2292927C (de) |
| DE (1) | DE69911557T2 (de) |
| DK (1) | DK1010693T3 (de) |
| EA (1) | EA004536B1 (de) |
| ES (1) | ES2209362T3 (de) |
| FR (1) | FR2787451B1 (de) |
| HK (1) | HK1027573A1 (de) |
| HU (1) | HUP9904628A3 (de) |
| NO (1) | NO314544B1 (de) |
| NZ (1) | NZ501785A (de) |
| PL (1) | PL202198B1 (de) |
| PT (1) | PT1010693E (de) |
| SI (1) | SI1010693T1 (de) |
| ZA (1) | ZA997734B (de) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA981080B (en) | 1997-02-11 | 1998-08-12 | Warner Lambert Co | Bicyclic inhibitors of protein farnesyl transferase |
| US6559157B2 (en) | 1997-10-02 | 2003-05-06 | Daiichi Pharmaceutical Co., Ltd. | Dihydronaphthalene compounds |
| DE69823222T2 (de) * | 1997-10-02 | 2005-04-14 | Daiichi Pharmaceutical Co., Ltd. | Dihydronaphthalinderivate und verfahren zur herstellung derselben |
| US6777441B2 (en) * | 2000-10-02 | 2004-08-17 | Emory University | Triptolide analogs for the treatment of autoimmune and inflammatory disorders |
| MX2007007103A (es) * | 2004-12-13 | 2008-03-10 | Lilly Co Eli | Derivados espiro como inhibidores de lipoxigenasa. |
| EP2173719A1 (de) * | 2007-07-03 | 2010-04-14 | F. Hoffmann-Roche AG | 4-imidazoline und ihre verwendung als antidepressiva |
| WO2009089285A2 (en) * | 2008-01-07 | 2009-07-16 | Emory University | Branched diepoxide compounds for the treatment of inflammatory disorders |
| US20100298305A1 (en) * | 2008-11-26 | 2010-11-25 | The United States Government, As Represented By The Department Of Veterans Affairs | Tizanidine for the treatment of post-traumatic stress disorder and nightmares |
| US8771391B2 (en) | 2011-02-22 | 2014-07-08 | Baker Hughes Incorporated | Methods of forming polycrystalline compacts |
| WO2015108136A1 (ja) * | 2014-01-17 | 2015-07-23 | キッセイ薬品工業株式会社 | α－置換グリシンアミド誘導体 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0115142B1 (de) * | 1982-12-23 | 1986-11-05 | Ici Americas Inc. | Chromanverbindungen |
| US4540705A (en) * | 1983-03-14 | 1985-09-10 | Sterling Drug Inc. | Antidepressant imidazolines and related compounds |
| FR2542738A1 (fr) * | 1983-03-18 | 1984-09-21 | Synthelabo | Indanyl-2 d2-imidazoline, procede pour la preparer, et compositions pharmaceutiques qui la contiennent |
| EP0166937B1 (de) * | 1984-06-06 | 1991-08-28 | Abbott Laboratories | Adrenergische Verbindungen |
| JPH01242571A (ja) * | 1988-03-22 | 1989-09-27 | Mitsui Petrochem Ind Ltd | イミダゾール誘導体の製造方法 |
| US5151526A (en) * | 1990-10-11 | 1992-09-29 | The United States Of America As Represented By The Secretary Of The Army | 4-[1-(1-naphthalenyl)ethyl]-1H-imidazole, method of making and use as an anesthetic |
| KR920008026A (ko) * | 1990-10-24 | 1992-05-27 | 오노 화아마슈티칼 캄파니 리미팃드 | 이소퀴놀리논 유도체 또는 이의 무독성 산부가염 또는 이의 수화물, 이의 제조방법 및 이를 포함하는 약제 조성물 |
| WO1994007866A1 (en) * | 1992-10-06 | 1994-04-14 | Tokyo Tanabe Company Limited | Aromatase inhibitor |
| DE19605400A1 (de) * | 1996-02-14 | 1997-08-21 | Bayer Ag | Salze von Imidazolin-Derivaten |
| FR2756560A1 (fr) * | 1996-12-04 | 1998-06-05 | Adir | Nouveaux derives de l'imidazoline, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
-
1998
- 1998-12-18 FR FR9815999A patent/FR2787451B1/fr not_active Expired - Fee Related
-
1999
- 1999-12-14 NZ NZ501785A patent/NZ501785A/xx not_active IP Right Cessation
- 1999-12-15 PL PL337196A patent/PL202198B1/pl not_active IP Right Cessation
- 1999-12-17 EA EA199901050A patent/EA004536B1/ru not_active IP Right Cessation
- 1999-12-17 AU AU65290/99A patent/AU767856B2/en not_active Ceased
- 1999-12-17 ZA ZA9907734A patent/ZA997734B/xx unknown
- 1999-12-17 CN CNB991261798A patent/CN1183907C/zh not_active Expired - Fee Related
- 1999-12-17 NO NO19996284A patent/NO314544B1/no not_active IP Right Cessation
- 1999-12-17 DE DE69911557T patent/DE69911557T2/de not_active Expired - Lifetime
- 1999-12-17 SI SI9930414T patent/SI1010693T1/xx unknown
- 1999-12-17 BR BR9907497-4A patent/BR9907497A/pt not_active Application Discontinuation
- 1999-12-17 AT AT99403190T patent/ATE250586T1/de not_active IP Right Cessation
- 1999-12-17 DK DK99403190T patent/DK1010693T3/da active
- 1999-12-17 PT PT99403190T patent/PT1010693E/pt unknown
- 1999-12-17 CA CA002292927A patent/CA2292927C/fr not_active Expired - Fee Related
- 1999-12-17 JP JP35859299A patent/JP3526800B2/ja not_active Expired - Fee Related
- 1999-12-17 ES ES99403190T patent/ES2209362T3/es not_active Expired - Lifetime
- 1999-12-17 EP EP99403190A patent/EP1010693B1/de not_active Expired - Lifetime
- 1999-12-17 HU HU9904628A patent/HUP9904628A3/hu unknown
- 1999-12-17 US US09/466,716 patent/US6127396A/en not_active Expired - Fee Related
- 1999-12-18 KR KR10-1999-0058936A patent/KR100492160B1/ko not_active IP Right Cessation
-
2000
- 2000-10-24 HK HK00106742A patent/HK1027573A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL114894A (en) | Pyrrolidine derivatives as endothelin antagonists, pharmaceutical compositions containing them, and their use in the preparation of medicaments | |
| DE69911557D1 (de) | Imidazoline Derivate,ihre Herstellung und pharmazeutische Zusammensetzungen die sie enthalten | |
| CA2119662A1 (fr) | Nouveaux derives bicycliques azotes, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
| DE69330601T2 (de) | Serotoninergische ergolin derivate | |
| ES2071786T3 (es) | Compuestos bloqueadores de nmda, composiciones farmaceuticas, su preparacion y su uso. | |
| MX9206930A (es) | Nuevos compuestos | |
| DE69910156D1 (de) | Spiroimidazolinderivate und ihre Verwendung als alpha2-Adrenorezeptor-Antagonisten und Monoamino-Wiederaufnahme-Blocker | |
| HU9602534D0 (en) | Use of biphenyl methyl imidazole derivatives for producing pharmaceutical compositions having ocular tension derpessant activity | |
| IL83216A (en) | 1((5-(10->9)abeo-6-methylergolin-8beta-yl)methyl)-imidazolidine-(and hexahydropyrimidine)-2,4-dione derivatives,their preparation and pharmaceutical compositions containing them | |
| DE69914563D1 (de) | Azaindol derivate und ihre Verwendung als antithrombotische Wirkstoffe | |
| ATE228359T1 (de) | Hemmung der leukotrienbiosynthese mittels harnstoffderivaten | |
| DE68909961D1 (de) | 2-Aminoacetamid Derivate. | |
| DK0952157T3 (da) | 9a, 11b-dehydroderivater af 9-oxim-3-keto-6-0-methylerythromycin | |
| DE69407227D1 (de) | Die Verwendung von 2-Phenylmethylene-1-3'-(amino)-2-(hydroxy)-propoxy-imino-cyclohexane-Derivaten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |